Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
EMBO Molecular Medicine|February 10, 2017
VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cellsKibeom Jang, Minsoon Kim, Candace A Gilbert, et al.
JAMA Network Open|November 26, 2024
Geographic Disparities in Gynecologic Oncology Clinical Trial Availability in the USMary Regina Boland, Elizabeth Tubridy, Sebastian Spataro Solorzano, et al.
BMC Medicine|March 29, 2011
Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancerCallinice D Capo-chichi, Kathy Q Cai, Fiona Simpkins, et al.
Gynecologic Oncology|September 2, 2023
Telehealth utilization in gynecologic oncology clinical trialsLeslie Andriani, Jinhee Oh, Erin McMinn, et al.
Gynecologic Oncology|August 23, 2023
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Frozen section underestimates the need for surgical staging in endometrial cancer patientsAndrea Papadia, Guglielmo Azioni, Bruno Brusacà, et al.
Gynecologic Oncology|March 28, 2021
Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumorsXiaoming Zhang, Kyle Devins, Emily M Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i>-Mutant Ovarian Cancer ModelsHyoung Kim, Erin George, Ryan Ragland, et al.
Gynecologic Oncology Reports|January 22, 2026
Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategiesMinyoung Jang, Stefan Gysler, Nawar A Latif, et al.
Gynecologic Oncology|December 12, 2022
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
Pageof 8